文献速递呼吸道感染肺栓塞与肺血管病

三腔室肺氧合破坏模型解释重症COVID-19的肺部及全身病理

A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19.
PubMed 文献 · Lancet Respir Med · 2021-05-14

本文提出三腔室肺氧合破坏模型,认为重症COVID-19中肺泡、肺动脉和支气管动脉三路氧供均受损,导致系统性血栓栓塞和肺泡-毛细血管屏障破坏,从而解释胸部早期疼痛、肺梗死及肺内外血栓栓塞等非典型临床病理特征。

要点

  • 重症COVID-19存在肺泡、肺动脉和支气管动脉三路氧供破坏。
  • 免疫血栓性阻塞肺及细支气管循环可致系统性血栓栓塞。
  • 肺泡-毛细血管屏障破坏使促血栓病毒物质进入体循环。

核心结论

  • 三腔室肺氧合破坏模型可涵盖重症COVID-19已知的病理和临床特征。

研究设计与样本

  • 本文为叙述性综述,基于21世纪β冠状病毒(含SARS-CoV-2)的临床病理观察提出模型。

主要发现

  • 早期胸痛、肺梗死及肺和系统性血栓栓塞与广泛毛细血管、小动脉和小静脉血栓形成病理相关。
  • CT早期磨玻璃影类似肺栓塞相关肺梗死,提示COVID-19存在新型血管病理。
  • 正常实质氧合由肺泡自身及肺动脉和支气管动脉双重供氧三源维持。
  • 重症COVID-19肺炎中三腔室均受损,伴严重病毒性肺泡炎及肺和细支气管循环免疫血栓性阻塞。
  • 三腔室破坏可致肺静脉区域免疫血栓形成引起的系统性栓子栓塞,以及肺泡-毛细血管屏障破坏使促血栓病毒物质进入体循环。

临床怎么用

  • 该模型提示免疫调节治疗可能在血管腔室内发挥抗炎效应,需关注患者对此类治疗的反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The emergent 21st century betacoronaviruses, including SARS-CoV-2, lead to clinicopathological manifestations with unusual features, such as early-onset chest pain, pulmonary infarction, and pulmonary and systemic thromboembolism that is pathologically linked to extensive capillary, arteriolar, and venular thrombosis. Early ground glass opacities detected by CT, which are reminiscent of lung infarcts associated with pulmonary embolism, point to a novel vascular pathology in COVID-19. Under physiological conditions, normal parenchymal oxygenation is maintained by three sources: the alveolus itself and dual oxygen supply from the pulmonary and bronchial artery circulations. We propose a model in which these three components are disrupted in COVID-19 pneumonia, with severe viral alveolitis and concomitant immunothrombotic obstruction of the pulmonary and bronchiolar circulation. Tricompartmental disruption might have two main consequences: systemic clot embolisation from pulmonary vein territory immunothrombosis, and alveolar-capillary barrier disruption with systemic access of thrombogenic viral material. Our model encompasses the known pathological and clinical features of severe COVID-19, and has implications for understanding patient responses to immunomodulatory therapies, which might exert an anti-inflammatory effect within the vascular compartments.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. McGonagle D, Bridgewood C, Meaney JFM, et al. A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19. Lancet Respir Med. 2021. PMID: 34000237. doi:10.1016/S2213-2600(21)00213-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。